查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1138395

全球生物可吸收植入物市场2022-2029

Global Bioresorbable Implants Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场动态

竞争对手对获得 FDA 批准的关注有望推动市场

近年来，许多生物可吸收植入物已成为各种适应症的可行替代品。这些可生物吸收的植入物在人体中溶解并取代天然骨骼。稍大的植入物需要与植入物集成的互连多孔组件，以实现更好的血管供应。增材製造技术允许直接製造这种相互连接的多孔结构。市场上的主要竞争对手专注于获得 FDA 批准用于治疗患者的新产品。例如，波士顿科学公司推出了由金属铂和铬组成的 SYNERGY 生物可吸收聚合物药物洗脱支架系统。该支架因其最佳的癒合特性和復杂病例的治疗选择而受到全球医生的高度评价。此外，根据 2021 年 5 月 23 日的新闻稿， Bioretec Ltd. 的 RemeOs 螺钉已获得 FDA 突破性设备指定，用于创伤学和骨科。新产品用于矫正骨折、畸形和错位。这些螺钉由生物活性合金製成，含有人体的天然元素，如镁、锌和钙，有助于促进新骨的形成。 2020年3月23日，Durysta（比马前列素植入物）获得美国食品药品监督管理局（Food and Drug Administration）（ FDA ）的批准，用于治疗开角型青光眼或高眼压症患者。植入物直接注入眼睛并在较长时间内释放比马前列素。因此，从上述陈述来看，预计将在预测期内推动市场。

约束

高昂的系统维护和安装成本、担心失去对外包流程的控制、对数据安全和服务质量的担忧以及经济战略的快速变化是在预测期内阻碍市场发展的一些因素。据信那

行业分析

生物可吸收植入物市场根据各种行业因素（包括未满足的需求、定价分析、供应链分析和监管分析）对市场进行深入分析。

COVID-19 影响分析

COVID-19 大流行对全球生物可吸收植入物市场产生了重大影响。这场大流行给全球医疗保健系统带来了压力，医院推迟了骨科手术等选择性手术，并限制了对生物可吸收植入物的需求。 COVID-19 正在限制化学和材料行业的运营并阻碍全球市场。供应链中断和原材料采购困难在一定程度上限制了生物可吸收植入物市场。儘管存在这些短期挑战，但预计生物可吸收植入物的全球市场在未来几年将经历显着增长。

生物可吸收植入物全球市场报告提供大约 45 多个市场数据表、40 多个数字和 180 页内容。

内容

第一章研究方法与范围

  • 调查方法
  • 调查范围

第 2 章定义和概述

第 3 章执行摘要

  • 按材料类型划分的市场细分
  • 按应用划分的市场细分
  • 最终用户的市场细分
  • 按地区划分的市场细分

第 4 章市场动态

  • 市场影响因素
  • 驱动程序
  • 限制因素
  • 影响分析

第五章产业力量

  • 波特五力分析
  • 供应链分析
  • 流行病学
  • 主要趋势及发展现状

第 6 章 COVID-19 分析

  • COVID-19 的市场分析

第 7 章按材料类型

  • 金属
  • 高分子材料
  • PLGA-聚乳酸-乙醇酸
  • PLLA-聚 L-丙交酯
  • PGA-聚乙醇酸
  • PLA聚乳酸
  • 其他

第 8 章按应用程序

  • 心脏病学
  • 骨科
  • 其他

第 9 章，最终用户

  • 医院
  • 门诊手术中心
  • 其他

第 10 章按地区划分

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 意大利
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第 11 章竞争格局

  • 竞争场景

第 12 章公司简介

  • Bioretec Ltd
    • 公司概况
    • 产品组合和描述
    • 主要亮点
    • 财务摘要
  • Stryker Corporation（Wright Medical）
  • ConMed Corporation
  • Syntellix AG
  • Johnson & Johnson Medical Devices（DePuy Synthes）
  • Zimmer Biomet Holdings
  • Becton, Dickinson and Company（C.R. Bard）
  • NuVasive Inc.
  • KLS Martin
  • Smith & Nephew
  • Medtronic Plc

第13章 DataM

简介目录
Product Code: DMMD887

Market Overview

Bioresorbable Implants Market size was valued US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 7.40% during the forecast period (2022-2029).

Bioabsorbable implants are the ones that absorb in the body. Bioresorbable materials used for the implants slowly diffuse in the human body, so a second surgery to remove the Synthetic material is not required. The materials used in bioabsorbable implants can be synthetic and natural. Bioabsorbable implants have a wide range of indications, from ocular implants to fixations of bone grafts.

Market Dynamics

Leading Competitors in the market are concentrating their efforts on obtaining FDA clearance is expected to drive the market.

Recently, many bioresorbable implants have been made available as a feasible alternative to various indications. These bioresorbable implants dissolve in the human body and then get replaced by natural bones. For the somewhat large implants, interconnecting porous assembly is needed so that it can be integrated with the implant for better vascularization. The additive manufacturing technology, this interconnecting porous structure can be manufactured directly. The leading competitors in the market are concentrating their efforts on obtaining FDA clearance for novel products to treat patients. For instance, Boston Scientific launched its SYNERGY Bioabsorbable Polymer Drug-Eluting Stent System consisting of platinum and chromium metals. This stent is highly accepted amongst physicians worldwide because of its optimal healing property and treatment options for complex cases. Also, on May 23, 2021, Bioretec Ltd. received FDA breakthrough device designation of its RemeOs Screws for use in traumatology and orthopedic surgery, according to a press release. The new products are intended for bone fractures and for correcting deformities or malalignments. Created from a bioactive alloy, the screws contain elements natural to the body, like magnesium, zinc and calcium, which help promote new bone formation. On March 23, 2020, Durysta (bimatoprost implant) received approval from the US Food and Drug Administration (FDA) for treating patients with open-angle glaucoma or ocular hypertension. The implant is administered directly into the eye, where it releases bimatoprost for an extended period. Thus, from the above statements, the market is expected to drive in the forecast period.

Restraint:

The high cost of system maintenance and installation, the fear of losing control over the outsourced process, concerns about data security and service quality, and rapid changes in economic strategies are some factors the market is expected to get hampered in the forecast period.

Industry Analysis

The bioresorbable implants market provides in-depth analysis of the market based on various industry factors such as unmet needs, pricing analysis, supply chain analysis, regulatory analysis etc.

COVID-19 Impact Analysis

The COVID-19 pandemic had a major impact on the global bioabsorbable implants market. The pandemic burdened healthcare systems globally and hospitals postponed elective surgeries such as orthopedic surgeries, restricting the demand for bioresorbable implants. COVID-19 has limited the operations of the chemicals and materials industry, hampering the global market. Supply chain disruptions and difficulty in procuring raw materials have somewhat restrained the bioresorbable implants market. Despite these short-term challenges, the global bioabsorbable implants market is expected to generate significant growth in the coming years.

Segment Analysis

PLGA- Poly lactic-co-glycolic acid segment is expected to be the dominant segment in the market during the forecast period.

The PLGA- Poly lactic-co-glycolic acid segment accounted for the largest market share in 2021. PLGA- Poly lactic-co-glycolic acid is one of the most strongly biodegradable polymers. It is an FDA-approved Generally Recognized as Safe (GRAS) polymer used in various resorbable surgical devices such as meshes, sutures and ligatures. PLGA is a copolymer for drug delivery owing to its mechanical properties, biodegradability, biocompatibility, and ease of processing. It has been used to provide various vascular tissue-engineering devices, such as grafts and prosthetic devices. Early generations of PGA resorbable implants have been known to cause local effects during bio-absorption, and the rapid degeneration of the implants may cause uncertainty before healing occurs. Specifically, PLGA materials are also developed for the dental field in films, membranes, nanoparticles or microparticles. PLGA membranes have been studied with promising results, alone or combined with other elements in bone healing procedures. Biocompatibility, flexibility, biodegradability and minimal side effects are the main benefits when using this polymer for biomedical applications. In particular, PLGA has mainly been studied to develop devices for the controlled delivery of small molecule drugs, proteins and other macromolecules in commercial use and research. Thus, from the above statements, the market segment accounted for the largest market share in the forecast period.

Geographical Analysis

North American region is expected to hold the largest market share in the global bioresorbable implants market.

The North American bioabsorbable implants market is expected to hold the largest regional share of the global market, owing to factors such as a high prevalence of cardiovascular disease and an increase in the geriatric population, which is expected to increase the number of cases of osteoporosis and osteoarthritis. Technological advancement in bioabsorbable implants, increasing medical innovation and approval of new implants by the FDA are also factors driving the growth of the North American market. For instance, Stryker has developed a new bioabsorbable implant, SonicAnchor, used for suture and tissue fixation. The implant employs ultrasonic energy to liquefy and flow into the cancellous bone for secure fixing. The device is suitable for suture or tissue fixation in ankle, foot, knee, wrist, hand, elbow, and shoulder open operations. Manufacturers are combining strategies to improve patient care. Moreover, in June 2022, a team of researchers from Northwestern University developed a new type of flexible bioabsorbable implant that relieves pain in patients without using drugs.

Competitive Landscape

Major key players in the bioresorbable implants market are Bioretec Ltd, Stryker Corporation, ConMed Corporation, Syntellix AG, Johnson & Johnson, Zimmer Biomet, Becton Dickinson and Company, KLS Martin, Smith and Nephew and Evonik Industries AG, among others.

Bioretec Ltd.:

Overview:

Bioretec Ltd. is a medical device company focusing on developing strong, safe and reliable bioabsorbable and bioresorbable implants for pediatric and adult orthopedics. The company's products are used worldwide, and it continues to develop materials and products for load-bearing further clinical applications. The company's work is under ISO 13485:2016 and FDA Part 820. All the Activa products hold CE certificates, and most are also 510(k) cleared by the FDA.

Product Portfolio:

RemeOs Screw bioresorbable magnesium implants: RemeOs bioresorbable metallic implants are in the clinical testing phase. These implants will offer a strong and bioresorbable solution for load-bearing medical operations. These implants eliminate implant removal while still maintaining strength and rigidity close to traditional steel or titanium implants.

The global bioresorbable Implants market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research methodology
  • 1.2. Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet by Material Type
  • 3.2. Market Snippet by Application
  • 3.3. Market Snippet by End-User
  • 3.4. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market Impacting Factors
  • 4.2. Drivers
  • 4.3. Restraints
  • 4.4. Impact Analysis

5. Industry Forces

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Epidemiology
  • 5.4. Key Trends and Developments

6. By COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market

7. By Material Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type
    • 7.1.2. Market Attractiveness Index, By Material Type
  • 7.2. Metallic*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2019-2027 and Y-o-Y Growth Analysis (%), 2020-2027
  • 7.3. Polymers
    • 7.3.1. Introduction
    • 7.3.2. Market Size Analysis, US$ Million, 2019-2027 and Y-o-Y Growth Analysis (%), 2020-2027
  • 7.4. PLGA- Polylactic-co-glycolic acid
  • 7.5. PLLA- Poly L-lactide
  • 7.6. PGA- Polyglycolic Acid
  • 7.7. PLA- Polylactic Acid
  • 7.8. Others

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Cardiovascular*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2019-2027 and Y-o-Y Growth Analysis (%), 2020-2027
  • 8.3. Orthopedics
  • 8.4. Others

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2019-2027 and Y-o-Y Growth Analysis (%), 2020-2027
  • 9.3. Ambulatory Surgical Centers
  • 9.4. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. South America
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Brazil
      • 10.3.6.2. Argentina
      • 10.3.6.3. Rest of South America
  • 10.4. Europe
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Germany
      • 10.4.6.2. U.K.
      • 10.4.6.3. France
      • 10.4.6.4. Spain
      • 10.4.6.5. Italy
      • 10.4.6.6. Rest of Europe
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East & Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

  • 11.1. Competitive Scenario

12. Company Profiles

  • 12.1. Bioretec Ltd*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Stryker Corporation (Wright Medical)
  • 12.3. ConMed Corporation
  • 12.4. Syntellix AG
  • 12.5. Johnson & Johnson Medical Devices (DePuy Synthes)
  • 12.6. Zimmer Biomet Holdings
  • 12.7. Becton, Dickinson and Company (C.R. Bard)
  • 12.8. NuVasive Inc.
  • 12.9. KLS Martin
  • 12.10. Smith & Nephew
  • 12.11. Medtronic Plc

13. DataM Intelligence

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us